SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-11-000010
Filing Date
2011-01-03
Accepted
2011-01-03 06:15:11
Documents
1
Group Members
CHRISTIAN HANSENCORA MADSENFLORIAN SCHONHARTINGNB PUBLIC EQUITY KOMPLEMENTAR APS

Document Format Files

Seq Description Document Type Size
1 v206967_sc13ga.htm SC 13G/A 129033
  Complete submission text file 0001144204-11-000010.txt   131185
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81821 | Film No.: 11500119
SIC: 2834 Pharmaceutical Preparations

Mailing Address OSTERGADE 5 3RD FLOOR DK-1100 COPENHAGEN K G7 -----
Business Address OSTERGADE 5 3RD FLOOR DK-1100 COPENHAGEN K G7 ----- 45 70 20 12 63
NB Public Equity K/S (Filed by) CIK: 0001451330 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A